Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double‐blind trial.
Authors:
- Jj BelchJBJj Belch
- J CormieJCJ Cormie
- P NewmanPNP Newman
- M McLarenMMM McLaren
- J BarbenelJBJ Barbenel
- H CapellHCH Capell
- P LeibermanPLP Leiberman
- Cd ForbesCFCd Forbes
- Cr PrenticeCPCr Prentice
- 1 February 1983
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 15 (S1) , 113S-116S
Abstract
1 UK‐37248 (dazoxiben), an orally active thromboxane synthetase inhibitor, was evaluated in a double‐blind trial of patients with severe Raynaud's syndrome. 2 Twenty patients were enrolled in the study. Eleven of these patients received dazoxiben 400 mg day and nine received matching placebo capsules. Treatment was given for 6 weeks and the patients reviewed at 2 weekly intervals during the study. 3 Assessment of response was judged by clinical symptoms and hand temperature measurements. Haematological and haemostatic studies were also carried out. 4 Results show a significant clinical improvement in patients receiving dazoxiben for six weeks. Hand temperature measurements, and haematological and haemostatic blood tests remained unchanged, however, apart from the expected lowering in plasma thromboxane B2 levels. 5 The mechanism of action of the drug would appear not to be mediated through increased prostacyclin production and further studies are under way to determine how improvement has been obtained in these patients.Keywords
This publication has 10 references indexed in Scilit:
- Raynaud syndromeSeminars in Arthritis and Rheumatism, 1981
- ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASEThe Lancet, 1981
- Successful Treatment of Raynaud's Syndrome with ProstacyclinThrombosis and Haemostasis, 1981
- The Effect On Serum-Thromboxan B2 Production, Platelet Aggregation, Serotonin Release, PF-4 And 6-Keto-PGF1αOf A Novel Specific Thromboxan A2 Synthetase-Inhibitor In Patients With Hyperactive Platelets1981
- Treatment of vasospastic disease with prostaglandin E1.BMJ, 1980
- Plasma exchange and platelet function in Raynaud's phenomenonThrombosis Research, 1980
- MEASUREMENT OF ERYTHROCYTE DEFORMABILITY USING MICROPORE MEMBRANES - SENSITIVE TECHNIQUE WITH CLINICAL APPLICATIONS1979
- Quantitative Thermographic Assessment of Inositol Nicotinate Therapy in Raynaud's PhenomenaJournal of International Medical Research, 1977
- Skin capillary blood flow in sclerodermaJournal of Clinical Investigation, 1971
- Raynaud's PhenomenonJAMA, 1962